Table 2.
Factor | Estimates | p Value |
---|---|---|
Grade of retinopathy | ||
None–mild NPDR | Reference | |
Moderate–severe NPDR | −2.271 | 0.096 |
PDR | −4.200 | 0.005* |
Age | −0.063 | 0.206 |
Male | 0.046 | 0.972 |
logMAR BCVA | −5.177 | 0.154 |
HgbA1c | −0.336 | 0.370 |
Type 2 DM | −1.844 | 0.149 |
Hypertension | −0.973 | 0.417 |
Hyperlipidaemia | −1.576 | 0.188 |
ETDRS zone | ||
Central foveal | Reference | |
Inner inferior | 34.725 | <0.001* |
Inner nasal | 34.484 | <0.001* |
Inner superior | 34.583 | <0.001* |
Inner temporal | 34.418 | <0.001* |
Outer inferior | 38.506 | <0.001* |
Outer nasal | 37.550 | <0.001* |
Outer superior | 38.479 | <0.001* |
Outer temporal | 38.224 | <0.001* |
p Values <0.05.
BCVA, best-corrected visual acuity; DM, diabetes mellitus; HbA1c, haemoglobin A1c; logMAR, logarithm of the minimum angle of resolution; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy.